From July 1, 2022 to December 31, 2022, the company has repurchased 2,335,000 shares, representing 0.41% for HKD 8 million. With this, the company has completed the repurchase of 3,132,000 shares, representing 0.55% for HKD 10.9 million under the buyback announced on May 12, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 HKD | +2.68% | -0.86% | -7.63% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.63% | 167M | |
-3.81% | 86.85B | |
+2.76% | 40.16B | |
-16.98% | 31.28B | |
+57.86% | 25.27B | |
-16.24% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
-17.10% | 11.69B | |
+6.89% | 8.83B |
- Stock Market
- Equities
- 1061 Stock
- News Essex Bio-Technology Limited
- Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.